Epsilon M&A Deal Report - Sebia
Transaction Multiples for the Valuation of Private Companies
Private Group led by Astorg Partners and Montagu Private Equity / Sebia
No EMAT :
64974
Announced Date :
02/06/2014
Type :
SBO (Secondary Buy Out) ,Exit
Deal Value :
Yes
Acquirer :
Private Group led by Astorg Partners and Montagu Private Equity
Target :
Sebia
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Diagnostic Medical Equipment
Business Description :
Founded in 1967, Sebia is a global IVD specialty company developing diagnostics solutions for biologists and physicians in the fields of oncology, haemoglobin disorders and metabolic disorders...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
- Number of EMAT Reports / sub-sector « Diagnostic Medical Equipment » = 37
| Date | Acquirer | Target | Country | Multiples | See details |
| 09/04/2014 | Private Group led by LBO Partners | Menix | France | * | 64965 |
| 24/04/2014 | Cerba | JS BIO | France | * | 64947 |
Source: Epsilon Research / EMAT
